These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12840712)

  • 21. SSRIs in the treatment of obsessive-compulsive disorder.
    Cartwright C; Hollander E
    Depress Anxiety; 1998; 8 Suppl 1():105-13. PubMed ID: 9809222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paroxetine and its uses in psychiatry.
    Bell C; Nutt D
    Hosp Med; 1999 May; 60(5):353-6. PubMed ID: 10396411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A question of balance.
    Ramchandani P
    Nature; 2004 Jul; 430(6998):401-2. PubMed ID: 15269742
    [No Abstract]   [Full Text] [Related]  

  • 25. SSRI-induced mania in obsessive-compulsive disorder.
    Diler RS; Avci A
    J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):6-7. PubMed ID: 9893408
    [No Abstract]   [Full Text] [Related]  

  • 26. [Unfortunate title?].
    Waern M; Agren H; Hägglöf B; Lundin B
    Lakartidningen; 2004 Jun; 101(26-27):2292. PubMed ID: 15281636
    [No Abstract]   [Full Text] [Related]  

  • 27. Paroxetine for treatment of obsessive-compulsive disorder and comorbid stuttering.
    Murray MG; Newman RM
    Am J Psychiatry; 1997 Jul; 154(7):1037. PubMed ID: 9210761
    [No Abstract]   [Full Text] [Related]  

  • 28. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine.
    Brody AL; Saxena S; Fairbanks LA; Alborzian S; Demaree HA; Maidment KM; Baxter LR
    J Clin Psychiatry; 2000 May; 61(5):349-55. PubMed ID: 10847309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactivity of serotonin in whole blood.
    Mulder EJ; Anderson GM; Kema IP; Minderaa RB
    Biol Psychiatry; 2002 Feb; 51(3):266-8. PubMed ID: 11839371
    [No Abstract]   [Full Text] [Related]  

  • 30. Ask the doctor. I have been taking an SSRI (paroxetine HCI) for many years for chronic anxiety and, at times, panic attacks. What are the side effects of the long-term use of SSRIs?
    Komaroff AL
    Harv Health Lett; 2012 Aug; 37(10):2. PubMed ID: 22991725
    [No Abstract]   [Full Text] [Related]  

  • 31. Paroxetine use in medically ill patients.
    Stout SS; Somerset WI; Miller A; Musselman DL
    Psychopharmacol Bull; 2003; 37 Suppl 1():108-22. PubMed ID: 14566206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents].
    Bailly D
    Presse Med; 2006 Sep; 35(9 Pt 2):1293-302. PubMed ID: 16969324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of pharmacologic treatments for obsessive-compulsive disorder.
    Kaplan A; Hollander E
    Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Withdrawal syndrome associated with abrupt discontinuation of SSRIs.
    Wincor MZ
    J Am Pharm Assoc (Wash); 1998; 38(4):500-1. PubMed ID: 9707961
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful treatment of severe antidepressant-induced nausea with a combination of milnacipran and olanzapine.
    Yoshida K; Higuchi H; Ozaki N
    Pharmacopsychiatry; 2007 Mar; 40(2):84-5. PubMed ID: 17447181
    [No Abstract]   [Full Text] [Related]  

  • 36. Association of paroxetine with suicide attempt in obsessive-compulsive disorder.
    Göder R; Friege L; Treskov V; Grohmann R; Aldenhoff JB
    Pharmacopsychiatry; 2000 May; 33(3):116-7. PubMed ID: 10855464
    [No Abstract]   [Full Text] [Related]  

  • 37. Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience.
    DeVane CL; Sallee FR
    J Clin Psychiatry; 1996 Feb; 57(2):55-66. PubMed ID: 8591970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
    Prescrire Int; 2000 Aug; 9(48):112-3. PubMed ID: 11067720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL; Jakubovski E; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.